Works by Li, Li-Ren


Results: 28
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15

    Cetuximab plus FOLFOXIRI versus cetuximab plus FOLFOX as conversion regimen in RAS/BRAF wild-type patients with initially unresectable colorectal liver metastases (TRICE trial): A randomized controlled trial.

    Published in:
    PLoS Medicine, 2024, v. 21, n. 5, p. 1, doi. 10.1371/journal.pmed.1004389
    By:
    • Wang, De-Shen;
    • Ren, Chao;
    • Li, Shan-Shan;
    • Fong, William Pat;
    • Wu, Xiao-Jun;
    • Xiao, Jian;
    • Li, Bin-Kui;
    • Zheng, Yun;
    • Ding, Pei-Rong;
    • Chen, Gong;
    • Qiu, Miao-Zhen;
    • Wang, Zhi-Qiang;
    • Wang, Feng-Hua;
    • Luo, Hui-Yan;
    • Wang, Feng;
    • Wang, Xiao-Zhong;
    • Wang, Ling-Yun;
    • Xie, De-Jin;
    • Chen, Tao;
    • Li, Li-Ren
    Publication type:
    Article
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26

    Safety of intraoperative chemotherapy with 5-FU for colorectal cancer patients receiving curative resection: a randomized, multicenter, prospective, phase III IOCCRC trial (IOCCRC).

    Published in:
    Journal of Cancer Research & Clinical Oncology, 2017, v. 143, n. 12, p. 2581, doi. 10.1007/s00432-017-2489-0
    By:
    • Zhang, Rong-xin;
    • Lin, Jun-zhong;
    • Lei, Jian;
    • Chen, Gong;
    • Li, Li-ren;
    • Lu, Zhen-hai;
    • Ding, Pei-rong;
    • Huang, Jiong-qiang;
    • Kong, Ling-heng;
    • Wang, Fu-long;
    • Li, Cong;
    • Jiang, Wu;
    • Ke, Chuan-feng;
    • Zhou, Wen-hao;
    • Fan, Wen-hua;
    • Liu, Qing;
    • Wan, De-sen;
    • Wu, Xiao-jun;
    • Pan, Zhi-zhong
    Publication type:
    Article
    27
    28